MS-275 (entinostat)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MS-275 (entinostat), covering 2025-11-19 to 2025-11-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Entinostat in Combination With Fulvestrant for the Treatment of Locally Advanced or Metastatic Breast Cancer [Phase 2]